PASG Passage BIO, Inc.

Fundamentals / CIK 0001787297 / USD

Passage BIO, Inc. reported $20.79M in total assets and a net loss of $33.08M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PASG in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$173.3MFY 2019 Net Income: -$45.63M2019FY 2020 Net Income: -$112.2M2020FY 2021 Net Income: -$185.4M2021FY 2022 Net Income: -$136.1M2022FY 2023 Net Income: -$102.1M2023FY 2024 Net Income: -$64.77M2024FY 2025 Net Income: -$45.52M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $23.28M $40.18M $61.42M $86.05M $117.7M $81.79M $29.74M
Operating Income -$49.30M -$70.40M -$108.4M -$138.4M -$185.7M -$112.9M -$37.19M
EBITDA -$48.57M -$67.32M -$104.7M -$134.7M -$184.2M -$112.1M -$37.05M
Interest Income -- -- -- -- $343K $670K $696K
Income Tax Expense $0 $0 -- -- -- -- --
Net Income -$45.52M -$64.77M -$102.1M -$136.1M -$185.4M -$112.2M -$45.63M
Basic EPS -$14.35 -$21.04 -$36.47 -$49.02 -$68.24 -$57.06 -$211.18
Diluted EPS -$14.35 -$21.04 -$36.47 -$49.02 -$68.24 -$57.06 -$211.18
Basic Shares Outstanding 3.2M 3.1M 2.8M 2.8M 2.7M 2.0M 216.0K
Diluted Shares Outstanding 3.2M 3.1M 2.8M 2.8M 2.7M 2.0M 216.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.50M $3.34M $4.09M $5.42M $4.31M $5.81M $7.74M $9.56M
Operating Income -$4.94M -$8.27M -$8.25M -$13.85M -$8.65M -$10.33M -$16.46M -$14.27M
EBITDA -$4.94M -$8.25M -$8.12M -$13.67M -$8.46M -$10.13M -$16.26M -$13.55M
Net Income -$4.72M -$7.82M -$7.56M -$12.98M -$7.75M -$9.38M -$15.40M -$12.72M
Basic EPS -$1.47 -$2.44 -$2.36 -- -$2.44 -$2.96 -$4.87 --
Diluted EPS -$1.47 -$2.44 -$2.36 -- -$2.44 -$2.96 -$4.87 --
Basic Shares Outstanding 3.2M 3.2M 3.2M -- 3.2M 3.2M 3.2M --
Diluted Shares Outstanding 3.2M 3.2M 3.2M -- 3.2M 3.2M 3.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $46.30M $37.57M $21.71M $34.60M $129.0M $135.0M $158.9M
Short-Term Investments $0 $39.18M $92.58M $155.0M $186.8M $169.8M --
Cash & Short-Term Investments $46.30M $76.76M $114.3M $189.6M $315.8M $304.8M $158.9M
Total Current Assets $47.76M $78.81M $118.0M $197.0M $325.1M $317.2M $165.8M
Property, Plant & Equipment, Net $4.11M $9.33M $15.29M $22.52M $23.81M $2.79M $1.09M
Other Non-Current Assets $244K $463K $433K $4.27M $6.20M $8.03M $11.75M
Total Non-Current Assets $14.52M $23.60M $32.59M $46.51M $30.01M $10.82M $12.84M
Total Assets $62.28M $102.4M $150.5M $243.5M $355.1M $328.0M $178.6M
Accounts Payable $1.11M $742K $1.30M $4.07M $9.45M $5.26M $629K
Deferred Revenue (Current) $13.75M $8.23M -- -- -- -- --
Other Current Liabilities -- -- $2.00M -- $500K $541K $46K
Total Current Liabilities $23.08M $19.36M $16.34M $18.35M $29.50M $21.18M $3.68M
Other Non-Current Liabilities -- -- -- -- -- $41K $76K
Total Non-Current Liabilities $20.44M $21.79M $22.92M $23.83M $6.92M $2.12M $580K
Total Liabilities $43.53M $41.15M $39.26M $42.18M $36.42M $23.29M $4.26M
Total Debt (incl. Leases) $24.01M $25.48M $26.29M $27.11M -- -- --
Common Stock -- $6.0K $5.0K $5.0K $5.0K $4.0K --
Retained Earnings -$704.8M -$659.2M -$594.5M -$492.4M -$356.3M -$170.9M -$58.66M
Accumulated Other Comp. Income -- $8.0K -$43K -$966K -$413K -$12K --
Total Stockholders' Equity $18.75M $61.26M $111.3M $201.4M $318.7M $304.7M -$56.25M
Total Equity $18.75M $61.26M $111.3M $201.4M $318.7M $304.7M -$56.25M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $20.16M $24.16M $33.34M $46.30M $52.77M $57.63M $63.36M $37.57M
Short-Term Investments $0 $0 $0 $0 $0 $0 -- $39.18M
Cash & Short-Term Investments $20.16M $24.16M $33.34M $46.30M $52.77M $57.63M $63.36M $76.76M
Total Current Assets $20.79M $25.18M $34.74M $47.76M $55.73M $60.31M $66.67M $78.81M
Property, Plant & Equipment, Net -- -- $826K $4.11M $5.16M $5.34M $5.52M $9.33M
Other Non-Current Assets -- -- $244K $244K $270K $270K $274K $463K
Total Non-Current Assets $0 $0 $1.72M $14.52M $18.43M $18.88M $19.34M $23.60M
Total Assets $20.79M $25.18M $36.46M $62.28M $74.16M $79.20M $86.01M $102.4M
Accounts Payable $533K $902K $1.31M $1.11M $952K $2.40M $1.46M $742K
Deferred Revenue (Current) $17.03M $16.25M $13.75M $13.75M $13.75M $9.74M $8.73M $8.23M
Total Current Liabilities $20.74M $20.72M $20.10M $23.08M $22.25M $19.80M $17.82M $19.36M
Total Non-Current Liabilities $0 $0 $4.61M $20.44M $20.80M $21.14M $21.48M $21.79M
Total Liabilities $20.74M $20.72M $24.71M $43.53M $43.04M $40.94M $39.30M $41.15M
Total Debt (incl. Leases) -- -- $5.75M $24.01M $24.34M $24.73M $25.12M $25.48M
Common Stock -- -- -- -- -- -- $6.0K $6.0K
Retained Earnings -$724.9M -$720.1M -$712.3M -$704.8M -$691.8M -$684.0M -$674.6M -$659.2M
Accumulated Other Comp. Income -- -- -- -- -- -- -- $8.0K
Total Stockholders' Equity $50K $4.46M $11.75M $18.75M $31.12M $38.26M $46.71M $61.26M
Total Equity $50K $4.46M $11.75M $18.75M $31.12M $38.26M $46.71M $61.26M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.52M -$64.77M -$102.1M -$136.1M -$185.4M -$112.2M -$45.63M
Depreciation & Amortization $728K $3.08M $3.72M $3.68M $1.54M $800K $134K
Stock-Based Compensation $3.00M $5.82M $10.92M $18.95M $32.69M $14.58M $1.45M
Change in Payables $1.88M -$556K -$2.79M -$5.41M $2.20M $4.59M $398K
Operating Cash Flow -$31.51M -$47.96M -$78.26M -$118.2M -$126.9M -$80.52M -$39.90M
Capital Expenditure -- -$34K -- -- -- -- --
Free Cash Flow -- -$47.99M -- -- -- -- --
Purchases of Investments -- -$88.17M -$129.4M -$157.8M -$202.5M -$266.1M --
Investing Cash Flow $40.22M $54.95M $65.24M $25.20M -$45.81M -$172.1M -$1.69M
Common Stock Issued -- -- -- -- $165.8M $228.3M --
Financing Cash Flow $23K $8.87M $135K -$1.35M $166.7M $228.8M $175.6M
Net Change in Cash $8.73M $15.86M -$12.89M -$94.36M -$6.04M -$23.87M $134.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.72M -$7.82M -$7.56M -$12.98M -$7.75M -$9.38M -$15.40M -$12.72M
Depreciation & Amortization $0 $25K $129K $177K $200K $200K $201K $719K
Stock-Based Compensation $313K $525K $556K $609K $611K $923K $858K $1.25M
Change in Payables -$369K -$408K $197K $161K $66K $937K $716K -$747K
Operating Cash Flow -$4.00M -$9.18M -$12.99M -$6.48M -$4.85M -$6.33M -$13.85M -$8.44M
Purchases of Investments -- -- -- -- -- -- -- -$15.58M
Investing Cash Flow $3.0K $0 $20K $0 $0 $585K $39.63M $13.68M
Financing Cash Flow -- -- -- -- -- -- -- $47K
Net Change in Cash -$4.00M -$9.18M -$12.97M -$6.47M -$4.85M -$5.73M $25.78M $5.28M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -242.7% -105.7% -91.7% -67.6% -58.2% -36.8% --
Return on Assets (ROA) -73.1% -63.2% -67.8% -55.9% -52.2% -34.2% -25.5%
Current Ratio 2.07x 4.07x 7.22x 10.74x 11.02x 14.98x 45.04x
Quick Ratio 2.01x 3.96x 6.99x 10.33x 10.70x 14.40x 43.16x
Debt to Equity 1.28x 0.42x 0.24x 0.13x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -66164.0% -810.4% -320.6% -242.7% -145.4% -148.6% -135.9% -105.7%
Return on Assets (ROA) -159.1% -143.4% -103.3% -73.1% -61.0% -71.8% -73.8% -63.2%
Current Ratio 1.00x 1.22x 1.73x 2.07x 2.51x 3.05x 3.74x 4.07x
Quick Ratio 0.97x 1.17x 1.66x 2.01x 2.37x 2.91x 3.55x 3.96x
Debt to Equity -- -- 0.49x 1.28x 0.78x 0.65x 0.54x 0.42x
Source: SEC EDGAR CompanyFacts (CIK 0001787297) · from March 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:06 UTC · Open in terminal